MMMir Hosein Seyyed Mohammadzad

Mir Hosein Seyyed Mohammadzad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mir Hosein Seyyed Mohammadzad has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of Triglyceride-Glucose Index with Severity of Myocardial Ischemia According to Myocardial Perfusion Imaging

    by Mir-Hossein Seyed-Mohammadzad, Saba Maleki, Reza Hajizadeh

    Objectives: To evaluate the relationship between ischemia detected by myocardial perfusion imaging (MPI) and triglyceride-glucose (TyG) index. Design: A cross-sectional study. Settings: All patients were referred to a tertiary hospital and underwent myocardial perfusion scanning. Participants: One hundred fifteen patients who underwent myocardial perfusion scanning. Outcome Measures: The formula LN [TG (mg/dL)×FBG (mg/dL)/2] was used to calculate the TyG index. The presence, severity, and extent of ischemia were determined based on the MPI reports. Results: The data from 115 patients, including 22 men (19.1%), with a mean age of 53.67±11.57 years, were analyzed in this study. The TyG index showed a significant association with the severity of ischemia as reported by MPI, increasing from 8.58±0.45 in non-ischemic patients to 9.6±0.33 in patients with severe ischemia. The final analysis revealed that a TyG index above 9.15, with a sensitivity of 68.4% and specificity of 84.2%, could predict a summed difference score of>0. Conclusions: A significant correlation was detected between the TyG index and ischemia using MPI.


  • Open Access

    The Relationship Between the Bilirubin Levels and Coronary Artery Disease in Patients With Stable Coronary Disease

    by Naser Khalili, Mir Hossein Seyed Mohammdazad, Sara Amiri

    Objectives: Coronary artery disease (CAD) is an atherosclerotic disease that is a major cause of mortality worldwide. Bilirubin has been considered an antioxidant that protects patients against atherosclerosis. Therefore, the present study examines the relationship between serum bilirubin levels with CAD. Methods: In this cross-sectional, analytical study, the patients with suspected CAD were electively scheduled for angiography. Their blood samples were measured for total, direct, and indirect bilirubin levels. Following angiography, comparisons were made between the two groups of CAD and non-CAD subjects. Results: Of 140 studied patients, 73(52.1%) were male and 67(47.9%) were female. The mean age of subjects was 55.32±10.71 years which was statistically significantly significant (P˂0.001). The mean total, direct, and indirect bilirubin levels between the groups were 0.74±0.57 (P=0.79), 0.22±0.07 (P=0.77), and 0.48±0.45 (P=0.77) mg/dL, respectively, which were not significant. The mean total (0.77±0.57 vs 0.71±0.57) and indirect bilirubin levels (0.53±0.53 vs 0.44±0.35) were higher in men than women and mean direct bilirubin was similar between men and women (0.23±0.07 vs 0.22±0.07). There was a statistically significant relationship between male and female groups in total and indirect bilirubin (P=0.05). Discussion: No significant relationship was found between bilirubin levels and CAD either in terms of protective or aggravating role.

  • Decreased Expression of Cytotoxic T lymphocyte-associated Protein 4: A Risk Factor of Myocardial Infarction

    by Fatemeh Mansouri, Mir Hosein Seyed Mohammadzad

    Cardiovascular diseases are the most prevalent disease worldwide and pose a considerable threat to human health. Cytotoxic T lymphocyte-associated protein 4 (CTLA-4) plays a crucial role in the maintenance of immune diseases; however, its role in the progression of cardiovascular disorders is still unknown. The present study aimed to evaluate the relationship between CTLA-4 and myocardial infarction (MI). The Kyoto encyclopedia of genes and genomes database and the pathway studio database has revealed the role of CTLA4 as an inhibitory receptor on activated T cells. The relative expression of the CTLA-4 gene was assessed on the peripheral blood cells in 80 MI patients and 80 healthy individuals using quantitative real-time polymerase chain reaction (qRT-PCR) and also receiver operating characteristic (ROC) analysis was performed to evaluate the sensitivity and specificity of CTLA-4. We noticed the decreased expression of CTLA-4 levels in patients, compared to the control group (2.73±1.55 vs. 5.36±1.34). The study revealed the sensitivity of 0.89, specificity of 0.83, the accuracy of 0.9, and the area under the ROC curve (AUC) of 0.901 (95% CI: 0.727-0.776) for CTLA-4. The results highlighted the critical role of CTLA-4 as an inhibitory receptor in the maintenance of cardiovascular risks.


  • Open Access

    The predictive value of serum klotho in diabetes mellitus and hypertension

    by Kamal Khademvatani, Zahra Yekta, Mirhosein Seyed Mohammadzad, Shahriar Khanahmadi, Roghaiyeh Afsargharehbagh, Leila Majdi, Alireza Rostamzadeh, Mojgan Hajahmadipoor Rafsanjani, Ali Soleimany, Elham Niknejad, et al.

    Introduction: Klotho allele status is associated with increased risk of cardiovascular diseases, diabetes and hypertension. Objectives: To determine if serum klotho level was lower among diabetic and hypertensive patients compared to control group. Patients and Methods: This was a cross-sectional study of 90 participants. Thirty pure diabetic patients and 30 participants with pure hypertension were compared with the healthy control group. Multiple logistic regressions were used to examine the association between serum klotho and diabetes and hypertension. We also tested the cut off point of serum klotho to predict hypertension and diabetes by using ROC (receiver operating characteristic) curve. Results: The level of serum klotho was significantly lower in diabetic and hypertensive patients. Participants with higher klotho were less likely to have diabetes and hypertension [OR: 0.48, 95% CI (0.22-0.81)] even after adjustment for covariates. ROC curve for diabetes and hypertension indicated 0.8 area under the curve which was statistically significant. Conclusion: This study found that serum klotho was associated with lower odds of diabetes and hypertension. Further longitudinal studies are necessary to confirm this finding.


  • Open Access

    The Study of Acute Myocardial Infarctions Triggers in North-Western Iran

    by Kamal Khademvatani, Amin Sedokani, Sima Masudi, Parisa Nejati, Mir Hosein Seyyed Mohammadzad, Alireza Rahmani

    Background: Myocardial infarction (MI) is one of the important cardiovascular diseases. A trigger is an external stimulus, potential to create a pathological change leading to a clinical event. In addition to the risk factors of myocardial infarction, MI triggers play critical roles in the incidence of acute MI. Methods and Results: This is a cross-sectional study of patients with the first acute myocardial infarction in Seyedoshohada heart center of Urmia, Iran. 254 patients were enrolled in the study within one year of study. After 48 h of hospitalization, the patients were provided with the questionnaire to collecting the history of the disease ad triggers. Out of 220 (86.4%) patients with STEMI and 34 (13.6%) patients with NSTEMI, there were significant differences (p 2 . Conclusion: In addition to classic risk factors of myocardial infarction, health care systems must pay more attention to triggers that may induce an acute myocardial infarction in people with predisposing factors especially in the male sex, stressful and hand working jobs, and psychological and mental tension patients.

  • Open Access

    Echocardiographic and Laboratory Findings in Coronary Slow Flow Phenomenon: cross-sectional study and review

    by Mir Hosein Seyyed Mohammadzad, Salar Gardeshkhah, Kamal Khademvatani, Amin Sedokani

    Background and aims: Coronary Slow flow is a phenomenon known as slow contrast flow that injected into the coronary arteries, without epicardial coronary arteries obstruction. The etiology of this disease is unknown. Endothelial dysfunction, known as a major cause of Coronary Slow flow syndrome (CSF). Methods: This study was cross-sectional (descriptive-analytic), which was performed on patients admitted to Seyedoshohada Heart Center, during one year (2018-2019). Considering the inclusion and exclusion criteria, patients were divided into two groups of normal coronary arteries (NECA, as the control group) and with the Coronary slow-flow (CSF). Results: In the present study, 124 patients were studied, 67.9% in the coronary slow flow group and 39.4% in the control group were men (p=0.001). In the coronary slow flow group, the mean age of patients was 52.18 ± 12.55 years and in the control group, the mean age was 51.77 ± 10.36 years (p=0.18). Mean BMI was significantly higher in the coronary slow flow group than the control group (p <0.05). The smoking, hypertension, and mean of Lymphocyte, Hb, Hct, Plt, MPV, RDW, BUN, FBS, TG, TC, LDL was significantly higher coronary slow flow group. Also, in echocardiography, the mean E wave, E/A ratio was significantly lower in the coronary slow flow group. The GLS was also significantly lower in the control group (p=0.01). LAD was the most common type of coronaries that involved with a slow flow. Conclusion: The results of this study showed that there was a significant increase in the rate of coronary slow flow in men, smokers, high BMI, and hypertensive patients. Also, platelet count, MPV, LDL, FBS, and some laboratory variables were high in patients with CSF. Mild diastolic dysfunction and low GLS were observed in this group of patients.


  • Open Access

    The association of serum vitamin D concentration and ventricular dysfunction among patients with acute coronary syndrome

    by Kamal Khademvatani, Mirhosein Seyed Mohammadzad, Zahra Yekta, Omid Hadizadeh

    Objective: To determine if vitamin D deficiency was associated with higher odds of left ventricular dysfunction among patients with acute coronary syndrome (ACS) and, if so, to determine whether this association was mediated by increased inflammation as measured by C-reactive protein (CRP) and white blood cell count (WBC). Methods: This was a cross-sectional study of 170 participants with ACS. Multiple logistic regression was used to examine the association between the outcome of ventricular performance and serum vitamin D concentrations. We also determined whether CRP and WBC meet standard criteria as the mediators between left ventricular ejection fraction and vitamin D deficiency. Results: Participants with vitamin D deficiency were more likely to have ventricular dysfunction (OR: 2.12, 95% CI: 1.2–5.23). WBC counts did not meet one of the criteria for mediation. However, the WBC was an effect modifier such that the association of vitamin D deficiency and ventricular dysfunction was only present among participants with WBC more than 11,000. Conclusion: This study found that vitamin D deficiency was associated with higher odds of ventricular dysfunction. Further longitudinal and experimental studies are necessary to confirm this finding and to determine if there is a role for vitamin D supplementation therapy in preventing ventricular dysfunction in select patient populations.


  • Open Access

    Short‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial

    by Yousef Rezaei, Kamal Khademvatani, Behzad Rahimi, Mehran Khoshfetrat, Nasim Arjmand, Mir‐Hossein Seyyed‐Mohammadzad

    Background: Contrast medium–induced acute kidney injury ( CIAKI ) is a leading cause of acquired renal impairment. The effects of antioxidants have been conflicting regarding the prevention of CIAKI . We performed a study of vitamin E use to decrease CIAKI in patients undergoing elective coronary angiography. Methods and Results: In a placebo‐controlled randomized trial at 2 centers in Iran, 300 patients with chronic kidney disease—defined as estimated glomerular filtration rate 2 —were randomized 1:1 to receive 0.9% saline infusion 12 hours prior to and after intervention combined with 600 mg vitamin E 12 hours before plus 400 mg vitamin E 2 hours before coronary angiography or to receive placebo. The primary end point was the development of CIAKI, defined as an increase ≥0.5 mg/dL or ≥25% in serum creatinine that peaked within 72 hours. Based on an intention‐to‐treat analysis, CIAKI developed in 10 (6.7%) and 21 (14.1%) patients in the vitamin E and placebo groups, respectively ( P =0.037). Change in white blood cell count from baseline to peak value was greater in the vitamin E group compared with the placebo group (−500 [−1500 to 200] versus 100 [−900 to 600]×10 3 /mL , P =0.001). In multivariate analysis, vitamin E (odds ratio 0.408, 95% CI 0.170–0.982, P =0.045) and baseline Mehran score (odds ratio 1.257, 95% CI 1.007–1.569; P =0.043) predicted CIAKI. Conclusions: Prophylactic short‐term high‐dose vitamin E combined with 0.9% saline infusion is superior to placebo for prevention of CIAKI in patients undergoing elective coronary angiography. Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 02070679.


  • Elective percutaneous coronary intervention without on-site cardiac surgery: an Iranian survey

    by Ramin Eskandari, Mir Hossein Seyyed Mohammadzadeh, Yousef Rezaei, Maryam Mehrpooya, Kamal Khademvatani, Alireza Rostamzadeh